_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
Watch the video from the 2021 PCCS Conference: ‘Addressing health inequalities in Heart Failure: a real world case study’.
Indication: Entresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.1
HFrEF, heart failure with reduced ejection fraction.
Reference
- Entresto Summary of Product Characteristics, 2021.